BDRX · Biodexa Pharmaceuticals Plc
$1.54
+0.07 (+4.76%)
At close · Aug 7
Market Cap
$1.33M
Shares
904,066
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-07-29 | — | |
| 6-K | 2026-07-09 | — | |
| 6-K | 2026-06-30 | — | |
| 6-K | 2026-06-30 | — | |
| 6-K | 2026-06-17 | — | |
| 6-K | 2026-05-14 | — | |
| 6-K | 2026-03-27 | — | |
| 20-F | 2026-03-27 | 2025-12-31 | |
| 6-K | 2026-03-18 | — | |
| 6-K | 2026-02-04 | — | |
| 6-K | 2026-01-06 | — | |
| 6-K | 2026-01-05 | — | |
| 6-K | 2025-12-18 | 2025-12-17 | |
| 6-K | 2025-11-03 | — | |
| 6-K | 2025-09-12 | 2025-06-30 | |
| 6-K | 2025-08-18 | — | |
| 6-K | 2025-07-31 | — | |
| 6-K | 2025-07-15 | — | |
| 6-K | 2025-06-27 | — | |
| 6-K | 2025-06-13 | — | |
| 6-K | 2025-06-11 | — | |
| 6-K | 2025-06-04 | — | |
| 6-K | 2025-05-30 | — | |
| 6-K | 2025-05-23 | — | |
| 6-K | 2025-05-22 | — | |
| 6-K | 2025-05-22 | — | |
| 6-K | 2025-05-15 | — | |
| 6-K | 2025-05-12 | — | |
| 6-K | 2025-05-02 | — | |
| 6-K | 2025-04-17 | — | |
| 6-K | 2025-04-11 | — | |
| 20-F | 2025-04-11 | 2024-12-31 | |
| 6-K | 2025-03-10 | — | |
| 6-K | 2025-03-06 | — | |
| 6-K | 2025-02-24 | — | |
| 6-K | 2025-02-13 | — | |
| 6-K | 2025-02-10 | — | |
| 6-K | 2025-01-22 | — | |
| 6-K | 2025-01-17 | — | |
| 6-K | 2024-12-27 | — | |
| 6-K | 2024-12-04 | — | |
| 6-K | 2024-11-12 | — | |
| 6-K | 2024-11-07 | — | |
| 6-K | 2024-11-01 | — | |
| 6-K | 2024-10-15 | — | |
| 6-K | 2024-10-04 | — | |
| 6-K | 2024-09-26 | 2024-06-30 | |
| 6-K | 2024-09-19 | — | |
| 6-K | 2024-09-16 | — | |
| 6-K | 2024-08-30 | — |
Showing 1–50 of 159 filings